Ftse Mib
34.151,41
-0,27%
DAX
18.498,38
0,32%
S&P 500
5.187,67
0,00%
NASDAQ
16.302,76
-0,18%
Bitcoin
61.623,62
-1,14%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Supernus Pharmaceuticals Inc (SUPN) Supernus Pharmaceuticals Inc (SUPN) Notizie

Supernus Pharmaceuticals Inc

SUPN
31,30
0,15 (0,48%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:05:27
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/5/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:08EDGAR2Form 8-K - Current report
08/5/202422:05GLOBESupernus Announces First Quarter 2024 Financial Results
07/5/202416:00PRNUSM8 Pharmaceuticals, an Acino company, signs an exclusive..
01/5/202414:00GLOBEBusy Philipps Shines Spotlight on ADHD in Women and Shares..
24/4/202422:05GLOBESupernus Pharmaceuticals to Announce First Quarter 2024..
08/4/202414:00GLOBESupernus Provides Regulatory Update for SPN-830
06/3/202422:30GLOBESupernus to Participate in Two Upcoming Investor Conferences
29/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202423:00EDGAR2Form 8-K - Current report
28/2/202422:30GLOBESupernus to Participate in the TD Cowen 44th Annual..
27/2/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202422:05GLOBESupernus Announces Fourth Quarter and Full Year 2023..
26/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:27EDGAR2Form 144 - Report of proposed sale of securities
22/2/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202420:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202413:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202422:08EDGAR2Form 8-K - Current report
13/2/202422:05GLOBESupernus Pharmaceuticals to Announce Fourth Quarter and Full..
05/2/202415:21EDGAR2Form 8-K - Current report
05/2/202414:30GLOBESupernus Wins Infringement and Validity Case on Trokendi XR®..
12/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:08EDGAR2Form 144 - Report of proposed sale of securities
26/12/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202313:30GLOBEKnight Therapeutics Enters into Exclusive License Agreement..
18/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202311:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
17/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202322:22EDGAR2Form 144 - Report of proposed sale of securities
14/11/202320:59EDGAR2Form 144 - Report of proposed sale of securities
08/11/202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:10EDGAR2Form 8-K - Current report
Apertura: 30,97 Min: 30,76 Max: 31,56
Chiusura: 31,15

La tua Cronologia

NASDAQ
SUPN
Supernus Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network